Lupus Innovation Award (LIA)
2021 Funded Grants
Identification of new genes that restrict TLR7 responses to self nucleic acids
Gregory Barton, PhD
University of California, Berkeley
Targeting the proteoglycan switch for lupus therapy
Nunzio Bottini, MD, PhD
Cedars-Sinai
Role of novel metabolite-receptor pathway in protection from lupus
Jason Cyster, PhD
University of California, San Francisco
Insights into lupus heterogeneity by single-cell profiling of B cell activation
Maria Gutierrez-Arcelus, PhD
Boston Children's Hospital
Linking the microbiome and the B cell repertoire to lupus nephritis
Bart Lambrecht, MD, PhD
VIB-UGent Center for Inflammation Research
Targeting pathogenic endothelial dysfunction in lupus nephritis
James Oates, MD
Medical University of South Carolina
Targeted regulatory T cells (Tregs) to treat lupus nephritis
Joshua Ooi, PhD
Monash University
Mechanisms of SCARF1 in regulating SLE
Zaida Ramirez-Ortiz, PhD
University of Massachusetts Medical School
Beyond serology: Improving the prediction and treatment of lupus with single cell Omics
Joanne Reed, PhD
Westmead Institute
The role of polyamine catabolism in the development of lupus
Betty Tsao, PhD
Medical University of South Carolina
Diversity of anti-NMDA receptor autoantibodies in lupus patients
Lonnie Wollmuth, PhD
Stony Brook University
2020 Funded Grants
Erythroid mitochondrial dysfunction in lupus pathogenesis
Simone Caielli, PhD
Weill Cornell Medical College
Mechanisms of vascular injury and dysfunction in pediatric lupus
Joyce Chang, MD
Boston Children's Hospital
cGAMP as an immune transmitter of the interferon response
Keith B. Elkon, MD
University of Washington
Multiplexed single-cell imaging in pediatric lupus nephritis
Elena Wen-Yuan Hsieh, MD
University of Colorado
Targeting a novel population of innate-like CD8+ Treg in lupus
Vipin Kumar, PhD
The Regents of University of California, San Diego
Modeling cognitive impairment in patients with systemic lupus erythematosus
Zahi Touma, MD, PhD
University Health Network
Targeting mTORC2 for lupus treatment
Hu Zeng, PhD
Mayo Clinic, Rochester, MN
2019 Funded Grants
The role of microglial subsets in driving neuropsychiatric symptoms of SLE
Carla Cuda, PhD
Northwestern University Feinberg School of Medicine
Contribution of dysregulated granulopoiesis to SLE pathogenesis
Neelakshi Jog, PhD
Oklahoma Medical Research Foundation
Shining a light on the drivers of photosensitivity in systemic lupus
Michelle Kahlenberg, MD, PhD
University of Michigan
Establishing the role of apoptosis and mtDNA in the pathobiology of lupus
Benjamin Kile, PhD
Monash University, Clayton, Australia
New mechanisms for thrombosis and atherosclerosis in SLE and APS
Yee Ling Wu, PhD
Loyola University Chicago Health Sciences Division
2018 Funded Grants
Ferroptosis as a novel driver of inflammation in lupus nephritis
Erika Boesen, PhD
University of Nebraska Medical Center
Examining the role of T cell exhaustion in lupus pathogenesis
Jeremy Tilstra, MD, PhD
University of Pittsburgh
2017 Funded Grants
Immunotargeting of T follicular helper (Tfh) cells for SLE treatment
Andre Ballesteros-Tato, PhD
University of Alabama at Birmingham
Neutrophil elastase as a therapeutic target in lupus
Jason S. Knight, MD, PhD
University of Michigan Medical School
Targeting nicotinic receptors to reduce inflammation associated with SLE
Keisa Williams Mathis, PhD
University of Texas Health Science Center at Fort Worth
Targeting EZH2 in lupus
Amr Sawalha, MD
University of Pittsburgh
2016 Funded Grants
Multi-level biomarkers for psychiatric disorders in pediatric lupus
Andrea Knight, MD, FRCPC
The Hospital for Sick Children